- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Impact of U.S. Preventive Services Task Force guideline raises concerns
Many urologists believe anecdotally that prostate cancer screening rates have declined since the US Preventive Services Task Force recommended against screening in 2012. Three studies presented at the AUA annual meeting appear to confirm that belief. Study authors and AUA spokesperson Sam Chang, MD, took a closer look at this issue and the most current data on trends in prostate cancer screening by primary care physicians.
Видео Impact of U.S. Preventive Services Task Force guideline raises concerns канала Urology Times
Видео Impact of U.S. Preventive Services Task Force guideline raises concerns канала Urology Times
U.S. Preventive Services Task Force prostate cancer men's health Urology times Urologists PSA screening Sam Chang Ryan werntz Oregon Health & Science University Hospital Urology of Vanderbeilt University Medical Center Jesse Sammon Brigham Young University (College/University) Women's Hospital in Boston Henry Ford Hospital (Hospital) Jennifer Yates University of Massachusetts USPSTF low-risk faverable PSA testing primary care primary care trends
Комментарии отсутствуют
Информация о видео
7 июля 2015 г. 19:14:11
00:04:07
Другие видео канала
African-Americans in the history of urology
Is there a urologist shortage? Sheila Gemar (AUA Annual Meeting)
Who benefits most from adding IO to BCG in NMIBC?
Limiting liability risk: A legal perspective
Alex Tatem, MD, discusses safety and risks of hyaluronic acid injections
Betty Wang, MD, and Laura Bukavina, MD, MPH, MSc, discuss ctDNA's role in NMIBC treatment decisions
Sophia Kamran, MD, discusses emerging trends shaping the future of bladder cancer management
Bilal Chughtai, MD, discusses cystoscopic outcomes with the Zenflow Spring System
Pearls & Perspectives: Prostate MRI and Focal Therapy, with Dan Sperling, MD, DABR
Dalia Kaakour, MD, MPH, on ctDNA in testicular cancer surveillance
ASCO GU recap: Vignesh Packiam, MD, on key bladder cancer highlights
Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MD
Prolapse surgery outcomes compared in nursing home residents, community-dwelling adults
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
